Medicine · Innovation · Healthy Living · Generosity
2 Musings — newest first.
Artificial intelligence, genetic risk, and the research shaping tomorrow's medicine.
Artificial intelligence is moving from promising predictions to real patient results. Dr. Engasser reviews two recent developments — an AI-assisted drug showing early promise against a hereditary colon-cancer condition, and AI that spots aortic valve calcification on routine chest CT scans — and explains why larger clinical trials are the critical next step.
Read MoreWhen several family members develop cancer, is it coincidence or an inherited genetic predisposition? Dr. Engasser explores hereditary cancer risk, genetic testing, early screening, and the exciting possibilities of blood-based cancer detection and gene editing. A little knowledge about your family history might make a lifesaving difference.
Read More